Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1983 1
1984 3
1986 3
1987 1
1988 2
1989 4
1991 2
1992 1
1993 1
1994 2
1995 3
1996 5
1998 1
2000 3
2001 2
2002 3
2003 5
2004 5
2005 1
2006 3
2007 1
2008 7
2009 6
2010 2
2011 1
2012 3
2013 3
2014 3
2015 5
2016 2
2017 5
2018 3
2019 2
2020 4
2021 5
2022 4
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

104 results

Results by year

Filters applied: . Clear all
Page 1
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trial.
Ho CY, Day SM, Axelsson A, Russell MW, Zahka K, Lever HM, Pereira AC, Colan SD, Margossian R, Murphy AM, Canter C, Bach RG, Wheeler MT, Rossano JW, Owens AT, Bundgaard H, Benson L, Mestroni L, Taylor MRG, Patel AR, Wilmot I, Thrush P, Vargas JD, Soslow JH, Becker JR, Seidman CE, Lakdawala NK, Cirino AL; VANISH Investigators; Burns KM, McMurray JJV, MacRae CA, Solomon SD, Orav EJ, Braunwald E. Ho CY, et al. Among authors: lever hm. Nat Med. 2021 Oct;27(10):1818-1824. doi: 10.1038/s41591-021-01505-4. Epub 2021 Sep 23. Nat Med. 2021. PMID: 34556856 Free PMC article. Clinical Trial.
Cardiac Remodeling in Subclinical Hypertrophic Cardiomyopathy: The VANISH Randomized Clinical Trial.
Vissing CR, Axelsson Raja A, Day SM, Russell MW, Zahka K, Lever HM, Pereira AC, Colan SD, Margossian R, Murphy AM, Canter C, Bach RG, Wheeler MT, Rossano JW, Owens AT, Benson L, Mestroni L, Taylor MRG, Patel AR, Wilmot I, Thrush P, Soslow JH, Becker JR, Seidman CE, Lakdawala NK, Cirino AL, McMurray JJV, MacRae CA, Solomon SD, Bundgaard H, Orav EJ, Ho CY; Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Investigators. Vissing CR, et al. Among authors: lever hm. JAMA Cardiol. 2023 Nov 1;8(11):1083-1088. doi: 10.1001/jamacardio.2023.2808. JAMA Cardiol. 2023. PMID: 37672268 Clinical Trial.
Ventricular Septal Myectomy for Obstructive Hypertrophic Cardiomyopathy (Analysis Spanning 60 Years Of Practice): AJC Expert Panel.
Maron BJ, Dearani JA, Smedira NG, Schaff HV, Wang S, Rastegar H, Ralph-Edwards A, Ferrazzi P, Swistel D, Shemin RJ, Quintana E, Bannon PG, Shekar PS, Desai M, Roberts WC, Lever HM, Adler A, Rakowski H, Spirito P, Nishimura RA, Ommen SR, Sherrid MV, Rowin EJ, Maron MS. Maron BJ, et al. Among authors: lever hm. Am J Cardiol. 2022 Oct 1;180:124-139. doi: 10.1016/j.amjcard.2022.06.007. Epub 2022 Aug 12. Am J Cardiol. 2022. PMID: 35965115 Free article. Review.
Why we need more septal myectomy surgeons: An emerging recognition.
Maron BJ, Dearani JA, Maron MS, Ommen SR, Rastegar H, Nishimura RA, Swistel DG, Sherrid MV, Ralph-Edwards A, Rakowski H, Smedira NG, Rowin EJ, Desai MY, Lever HM, Spirito P, Ferrazzi P, Schaff HV. Maron BJ, et al. Among authors: lever hm. J Thorac Cardiovasc Surg. 2017 Nov;154(5):1681-1685. doi: 10.1016/j.jtcvs.2016.12.038. Epub 2017 Feb 1. J Thorac Cardiovasc Surg. 2017. PMID: 28268009 Free article. No abstract available.
Imaging phenotype versus genotype in hypertrophic cardiomyopathy.
Desai MY, Ommen SR, McKenna WJ, Lever HM, Elliott PM. Desai MY, et al. Among authors: lever hm. Circ Cardiovasc Imaging. 2011 Mar;4(2):156-68. doi: 10.1161/CIRCIMAGING.110.957936. Circ Cardiovasc Imaging. 2011. PMID: 21406662 Review. No abstract available.
Percutaneous transluminal septal myocardial ablation.
Rubin DN, Tuzcu EM, Lever HM. Rubin DN, et al. Among authors: lever hm. Curr Cardiol Rep. 2000 Mar;2(2):160-5. doi: 10.1007/s11886-000-0014-5. Curr Cardiol Rep. 2000. PMID: 10980888 Review.
A Physician's Perspective on Generic Drug Quality.
Lever HM. Lever HM. J Manag Care Spec Pharm. 2020 May;26(5):592-593. doi: 10.18553/jmcp.2020.26.5.592. J Manag Care Spec Pharm. 2020. PMID: 32347170 Free PMC article.
Transforming Growth Factor-β Analysis of the VANISH Trial Cohort.
Kim Y, Mastali M, Van Eyk JE, Orav EJ, Vissing CR, Day SM, Axelsson Raja A, Russell MW, Zahka K, Lever HM, Pereira AC, Murphy AM, Canter C, Bach RG, Wheeler MT, Rossano JW, Owens AT, Bundgaard H, Benson L, Mestroni L, Taylor MRG, Patel AR, Wilmot I, Thrush P, Soslow JH, Becker JR, Seidman CE, Ho CY; VANISH Investigators. Kim Y, et al. Among authors: lever hm. Circ Heart Fail. 2023 Apr;16(4):e010314. doi: 10.1161/CIRCHEARTFAILURE.122.010314. Epub 2023 Mar 31. Circ Heart Fail. 2023. PMID: 36999957 Free PMC article. No abstract available.
104 results